The influence of pulmonary comorbidities on treatment choice and short-term surgical outcomes among elderly patients with colorectal cancer
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Colorectal Disease"
DOI: 10.1007/s00384-019-03336-9
Abstract: Most elderly patients with colorectal cancer have comorbidities and reduced functional reserve, which may increase their risks of postoperative morbidity and mortality, and subsequently influence the treatment choice. Therefore, this study aimed to investigate the… read more here.
Keywords: surgery; treatment; colorectal cancer; treatment choice ... See more keywords
Paracetamol: Useful treatment of choice for persistent arterial duct in very low weight premature newborns
Sign Up to like & getrecommendations! Published in 2018 at "Anales De Pediatria"
DOI: 10.1016/j.anpede.2017.07.004
Abstract: eosinophilic gastritis, respectively. Recently, Choi et al. published a study assessing the clinical, endoscopic and histologic features and the response to treatment of 13 children with a histological diagnosis of EGE. They found that the… read more here.
Keywords: treatment; choice persistent; treatment choice; useful treatment ... See more keywords
Factors Associated with Type 2 Diabetes Mellitus Treatment Choice Across Four European Countries.
Sign Up to like & getrecommendations! Published in 2017 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2017.09.016
Abstract: PURPOSE The aim of this analysis was to identify factors associated with the choice of type 2 diabetes mellitus (T2DM) therapy at the time of intensification of antidiabetic treatment across 4 European countries. METHODS Antidiabetic… read more here.
Keywords: united kingdom; line; treatment; treatment choice ... See more keywords
Is ravulizumab the new treatment of choice for atypical hemolytic uremic syndrome (aHUS)?
Sign Up to like & getrecommendations! Published in 2020 at "Kidney international"
DOI: 10.1016/j.kint.2020.03.011
Abstract: Ravulizumab, a new long-acting C5 inhibitor, recently received FDA approval for the treatment of aHUS. Rates of complete thrombotic microangiopathy response were similar to those observed in major eculizumab trials; however, fewer patients in the… read more here.
Keywords: treatment; treatment choice; choice atypical; ravulizumab new ... See more keywords
Impact of AJCC 8th edition staging system and definitive treatment choice on the prognosis of complete responders with p16+ and p16- oropharyngeal squamous cell carcinomas.
Sign Up to like & getrecommendations! Published in 2022 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2022.105861
Abstract: OBJECTIVES To identify predictors of overall survival (OS) in oropharyngeal squamous cell carcinoma (OPSCC) patients who achieved complete response (CR). METHODS We performed a retrospective study of OPSCC patients who achieved CR from a single… read more here.
Keywords: oropharyngeal squamous; treatment; treatment choice; opscc patients ... See more keywords
Treatment choice in single‐sided deafness and asymmetric hearing loss. A prospective, multicentre cohort study on 155 patients
Sign Up to like & getrecommendations! Published in 2020 at "Clinical Otolaryngology"
DOI: 10.1111/coa.13672
Abstract: To describe the treatment choice in a cohort of subjects with single‐sided deafness (SSD) and asymmetric hearing loss (AHL). To assess the reliability of the treatment trials. read more here.
Keywords: single sided; hearing loss; treatment; treatment choice ... See more keywords
Impact of Health-Related Quality of Life and Prediagnosis Risk of Major Depressive Disorder on Treatment Choice for Stage I Lung Cancer.
Sign Up to like & getrecommendations! Published in 2019 at "JCO clinical cancer informatics"
DOI: 10.1200/cci.19.00072
Abstract: PURPOSE We hypothesized that prediagnosis depressive symptoms and patient-reported health-related quality of life (HRQOL) would be associated with treatment choice for stage I non-small-cell lung cancer (NSCLC). METHODS Using the SEER and Medicare Health Outcomes… read more here.
Keywords: treatment choice; stage; health; risk ... See more keywords
Is there a role for histology based treatment choice in advanced gastric cancer (GC)
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.135
Abstract: 135Background: Medical management of advanced GC is mostly dependent on prognostic assessment based on tumor stage (TNM) and clinical patients (pts)’ characteristics, other than HER2 expression. Prognostic and predictive factors are clearly needed, and histotype… read more here.
Keywords: role histology; treatment choice; based treatment; oncology ... See more keywords